Necati Ormeci
Overview
Explore the profile of Necati Ormeci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C, et al.
Hepatol Int
. 2025 Feb;
PMID: 40016576
Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association...
2.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
3.
Shukla A, Rockey D, Kamath P, Kleiner D, Singh A, Vaidya A, et al.
Hepatol Int
. 2024 Nov;
18(6):1684-1711.
PMID: 39546143
Since the Asian Pacific Association for the Study of the Liver (APASL) published guidelines on non-cirrhotic portal fibrosis/idiopathic portal hypertension in 2007, there has been a surge in new information,...
4.
Ozercan M, Melekoglu Ellik Z, Parmaksiz A, Gumussoy M, Duman S, Ormeci N
Turk J Gastroenterol
. 2024 Aug;
35(8):634-642.
PMID: 39150398
The presence of liver fibrosis is the most important indicator of progression to cirrhosis. Noninvasive measurement of liver stiffness is crucial for detecting fibrosis. Vibration-controlled transient elastography is one of...
5.
Ormeci N, Asiller O, Parmaksiz A, Kalkan C, Ustuner E, Altinel A, et al.
Turk J Gastroenterol
. 2024 Aug;
35(5):398-407.
PMID: 39115158
No abstract available.
6.
Alswat K, Soliman R, Mikhail N, Ormeci N, Dalekos G, Derbala M, et al.
Saudi J Gastroenterol
. 2024 Mar;
30(3):138-144.
PMID: 38482630
Background: We recently developed a simple novel index called fibrosis 6 (FIB-6) using machine learning data analysis. We aimed to evaluate its performance in the diagnosis of liver fibrosis and...
7.
Anushiravani A, Alswat K, Dalekos G, Zachou K, Ormeci N, Al-Busafi S, et al.
Eur J Gastroenterol Hepatol
. 2023 Sep;
35(11):1284-1288.
PMID: 37695595
Background And Aims: We previously developed and validated a non-invasive diagnostic index based on routine laboratory parameters for predicting the stage of hepatic fibrosis in patients with chronic hepatitis C...
8.
Yu Q, Huang Y, Li X, Pavlides M, Liu D, Luo H, et al.
Cell Rep Med
. 2022 May;
3(3):100563.
PMID: 35492878
The hepatic venous pressure gradient (HVPG) is the gold standard for cirrhotic portal hypertension (PHT), but it is invasive and specialized. Alternative non-invasive techniques are needed to assess the hepatic...
9.
Liu Y, Tang T, Ormeci N, Huang Y, Wang J, Li X, et al.
J Clin Transl Hepatol
. 2021 Dec;
9(6):818-827.
PMID: 34966645
Background And Aims: This study aimed to determine the performance of the non-invasive score using noncontrast-enhanced MRI (CHESS-DIS score) for detecting portal hypertension in cirrhosis. Methods: In this international multicenter,...
10.
Shiha G, Soliman R, Mikhail N, Alswat K, Abdo A, Sanai F, et al.
Hepatol Res
. 2021 Nov;
52(2):165-175.
PMID: 34767312
Background: Non-invasive tests (NITs), such as Fibrosis-4 index (FIB-4) and the aspartate aminotransferase-to-platelet ratio index (APRI), developed using classical statistical methods, are increasingly used for determining liver fibrosis stages and...